The European Union health agency on Monday warned that Europe was set to miss goals on reducing the use of antibiotics, ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Phase 3 CTCL Trial to Initiate Before End of 2024 Soligenix, Inc.

A European Medicines Agency committee had said in July that the medicine, called Leqembi, should be rejected, citing the modest benefits seen in trials and the potentially dangerous side effects ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Patient involvement in health policy is a patchwork across the EU. Putting the lived experience front and centre of policy-making was prioritised at a recent high-level policy event organised by the ...

The European Union's drugs regulator on Thursday recommended approval for Eisai and Biogen's Leqembi in some patients with ...

How EU-M4All works EU-M4all runs at the same time as the European Medicine Agency’s approval process (to save time). This helps countries outside of the European Union to speed up their own checks ...

The authorities said the risk of a rapid spread remained low because the new cases had had household contact with the first infected person.

Experts say the risk of a new mpox strain spreading in the UK is "extremely low" after it was confirmed someone in London was ...